[go: up one dir, main page]

PT90296A - Processo para a preparacao de anticorpos monoclonais contra pseudomonas aeruginosa e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de anticorpos monoclonais contra pseudomonas aeruginosa e de composicoes farmaceuticas que os contem

Info

Publication number
PT90296A
PT90296A PT90296A PT9029689A PT90296A PT 90296 A PT90296 A PT 90296A PT 90296 A PT90296 A PT 90296A PT 9029689 A PT9029689 A PT 9029689A PT 90296 A PT90296 A PT 90296A
Authority
PT
Portugal
Prior art keywords
pseudomones
aeruginose
contain
preparation
pharmaceutical compositions
Prior art date
Application number
PT90296A
Other languages
English (en)
Other versions
PT90296B (pt
Inventor
Horst Domdey
Matthias Maget
Bernd-Ulrich Von Specht
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT90296A publication Critical patent/PT90296A/pt
Publication of PT90296B publication Critical patent/PT90296B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT90296A 1988-04-19 1989-04-18 Processo para a preparacao de anticorpos monoclonais contra pseudomonas aeruginosa e de composicoes farmaceuticas que os contem PT90296B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3813023A DE3813023A1 (de) 1988-04-19 1988-04-19 Monoklonaler antikoerper gegen pseudomonas aeruginosa, seine herstellung und verwendung

Publications (2)

Publication Number Publication Date
PT90296A true PT90296A (pt) 1989-11-10
PT90296B PT90296B (pt) 1995-01-31

Family

ID=6352325

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90296A PT90296B (pt) 1988-04-19 1989-04-18 Processo para a preparacao de anticorpos monoclonais contra pseudomonas aeruginosa e de composicoes farmaceuticas que os contem

Country Status (10)

Country Link
EP (1) EP0338395B1 (pt)
JP (1) JPH0213376A (pt)
KR (1) KR890016165A (pt)
AT (1) ATE116374T1 (pt)
AU (1) AU622446B2 (pt)
DE (2) DE3813023A1 (pt)
DK (1) DK186289A (pt)
ES (1) ES2065932T3 (pt)
FI (1) FI891816L (pt)
PT (1) PT90296B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5675790A (en) * 1989-05-09 1990-11-29 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
CA2038978A1 (en) * 1990-04-06 1991-10-07 Richard P. Darveau Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
AU2006307018B2 (en) * 2005-10-28 2012-10-25 Meiji Seika Kaisha, Ltd. Outer coat protein PA5158 of Pseudomonas aeruginosa
US8715941B2 (en) 2007-11-16 2014-05-06 Arca Biopharma, Inc. Antibodies to LRP6
US9290573B2 (en) 2010-05-06 2016-03-22 Novartis Ag Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies
ES2659406T3 (es) 2010-05-06 2018-03-15 Novartis Ag Composiciones y procedimientos de uso para anticuerpos terapéuticos contra la proteína 6 relacionada con las lipoproteínas de baja densidad (LRP6)
MX2014005411A (es) 2011-11-04 2015-02-12 Novartis Ag Construcciones prolongadas de la vida media de la proteina relacionada con lipoproteina de baja densidad 6 (lrp6).

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
JPS63267295A (ja) * 1986-12-03 1988-11-04 Sumitomo Chem Co Ltd ヒト抗体、抗体遺伝子及び対応する組換え体
US4870161A (en) * 1987-09-25 1989-09-26 The United States Of America As Represented By The Department Of Health And Human Services Reagents and probes for distinguishing and isolating different GTP-binding proteins
DK8189A (da) * 1988-01-12 1989-07-13 Bunge Australia Antigen-antistof-konjugater, deres fremstilling og anvendelse
WO1990012088A1 (en) * 1989-04-13 1990-10-18 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce MONOCLONAL ANTIBODIES TO HUMAN GLUTATHIONE S TRANSFERASE Pi

Also Published As

Publication number Publication date
FI891816A0 (fi) 1989-04-17
DK186289A (da) 1989-12-18
EP0338395A3 (en) 1990-03-28
PT90296B (pt) 1995-01-31
DE3813023A1 (de) 1989-11-16
KR890016165A (ko) 1989-11-28
ATE116374T1 (de) 1995-01-15
AU622446B2 (en) 1992-04-09
ES2065932T3 (es) 1995-03-01
AU3310189A (en) 1989-10-26
EP0338395A2 (de) 1989-10-25
EP0338395B1 (de) 1994-12-28
FI891816A7 (fi) 1989-10-20
DE58908815D1 (de) 1995-02-09
DK186289D0 (da) 1989-04-18
JPH0213376A (ja) 1990-01-17
FI891816L (fi) 1989-10-20

Similar Documents

Publication Publication Date Title
PT93536A (pt) Processo para a preparacao de anticorpos monoclonais (acm) contra antigenes associadas a tumores e de composicoes farmaceuticas e de diagnostico que os contem
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
PT90296A (pt) Processo para a preparacao de anticorpos monoclonais contra pseudomonas aeruginosa e de composicoes farmaceuticas que os contem
ATE67507T1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT92235A (pt) Processo para a preparacao de um anticorpo monoclonal anti-fucosilceramida e de agentes de diagnostico que o contem
AU5583286A (en) E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
SE8704114D0 (sv) Monoclonal antibody, a process for its preparation and the use thereof
ZA868673B (en) Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
GR3015489T3 (en) Monoclonal antibodies and process for the diagnosis of phytophtora infections.
FI875475A7 (fi) Hiiren hybridoma Lym-1 ja sillä tuotettu diagnostinen vasta-aine.
NO872633L (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
NO905006L (no) Humane, monoklonale antistoffer med reaktiviter overfor pseudomonas aeruginosa, celler som kan produsere antistoffene, fremgangsmaater for fremstilling derav og farmasoeytiskepreparater derav.
ATE86634T1 (de) Humaner monoklonaler antikoerper gegen pseudomonas aeruginosagegen pseudomonas aeruginosa produzierende hybridomen.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940719

PC3A Transfer or assignment

Free format text: 970814 CHIRON BEHRING GMBH AND CO. DE

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090719